ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,932, issued on Sept. 22, was assigned to AUTOBAHN THERAPEUTICS INC. (San Diego).
"Isotopic thyromimetic compounds" was invented by Bradley Backes (San Francisco) and Thomas von Geldern (Richmond, Ill.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Isotopic compounds are provided that function as thyromimetics, which compounds have utility for treating diseases such as neurodegenerative disorders. Pharmaceutical compositions containing such compounds are also provided, as are methods of their use and preparation."
The patent was filed on June 3, 2021, under Application No. 18/000,508.
*For further information, including images, charts and tables, ...